References
- Coura JR. Chagas disease: what is known and what is needed – a background article. Mem Inst Oswaldo Cruz 2007;102:113–22
- Soares MBP, Pontes-De-Carvalho L, Ribeiro-dos-Santos R. The pathogenesis of Chagas’ disease: when autoimmune and parasite-specific immune responses meet. Acad Bras Cienc 2001;73:547–59
- Antonio Marin-Neto SJ, Cunha-Neto E, Maciel BC, Simões MV. Pathogenesis of chronic Chagas heart disease. Circulation 2007;115:1109–23
- Coura JR, Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2000;97:3–21
- Fricker SP. Metal based drugs: from serendipity to design. Dalton Trans 2007;43:4903–17
- Sanchez-Delgado RA, Anzellotti A. Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis. Mini Rev Med Chem 2004;4:23–30
- Caffrey CR, Scory S, Steverding D. Cysteine proteinases of trypanosome parasites: novel targets for chemotherapy. Curr Drug Targets 2000;1:155–62
- Krauth-Siegel RL, Coombs GH. Enzymes of parasite thiol metabolism as drug targets. Parasitol Today 1999;15:404–9
- Vieites M, Smircich P, Parajo-Costa B, et al. Platinum-based complexes of bioactive 3-(5-nitrofuryl)acroleine thiosemicarbazones showing anti-Trypanosoma cruzi activity. J Biol Inorg Chem 2008;13:733–5
- Silva JJN, Osakabe AL, Pavanelli WR, et al. In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors. Brit J Pharmacol 2007;152:112–21
- Fricker SP, Mosi RM, Cameron B, et al. Metal compounds for the treatment of parasitic diseases. J Inorg Biochem 2008;102:1839–45
- Otero L, Vieites M, Boianí L, et al. Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets. J Med Chem 2006;49:3322–31
- Navarro M, Lehmann T, Cisneros-Fajardo EJ, et al. Toward a novel metal-based chemotherapy against tropical diseases. Part 5. Synthesis and characterization of new Ru(II) and Ru(III) clotrimazole and ketoconazole complexes and evaluation of their activity against Trypanosoma cruzi. Polyhedron 2000;19:2319–25
- Silva JJN, Pavanelli WR, da Silva ABF, et al. Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy. J Med Chem 2008;51:4104–14
- Donnici CL, Araújo MH, Oliveira HS, et al. Ruthenium complexes endowed with potent anti-Trypanosoma cruzi activity: synthesis, biological characterization and structure–activity relationships. Bioorg Med Chem 2009;15:5038–43
- Bernhardt PV, Sharpe PC, Islam M, et al. Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors. J Med Chem 2009;52:407–15
- Scozzafava A, Carta F, Supuran CT. Secondary and tertiary sulfonamides: a patent review (2008–2012). Expert Opin Ther Pat 2013;23:203--13
- Chohan ZH, Supuran CT. Structural elucidation and biological significance of 2-hydroxy-1-naphthaldehyde derived sulfonamides and their first row d-transition metal chelates. J Enzyme Inhib Med Chem 2008;23:240–51
- Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;26:759–72
- Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81
- De Simone G, Vitale RM, Di Fiore A, et al. Carbonic anhydrase inhibitors: hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX. J Med Chem. 2006;49:5544–51
- Chohan ZH, Shad HA. Metal-based new sulfonamides: design, synthesis, antibacterial, antifungal, and cytotoxic properties. J Enzyme Inhib Med Chem 2012;27:403–12
- Chohan ZH, Shad HA, Supuran CT. Synthesis, characterization and biological studies of sulfonamide Schiff’s bases and some of their metal derivatives. J Enzyme Inhib Med Chem 2012;27:58–68
- Leite ACL, Moreira DRM, Cardoso MVO, et al. Synthesis, Cruzain docking, and in vitro studies of aryl-4-oxothiazolylhydrazones against Trypanosoma cruzi. ChemMedChem, 2007;2:1339–45
- Moreira DRM, Leite ACL, dos Santos RR, Soares MBP. Approaches for the development of new anti-Trypanosoma cruzi agents. Curr Drug Targets 2009;10:212–31
- Mahnken RE, Billadeau MA, Nikonowicz EP, Morrison H. Development of photo cis-platinum reagents. Reaction of cis-dichlorobis(1,10-phenanthroline) rhodium(III) with calf thymus DNA, nucleotides and nucleosides. J Am Chem Soc 1992;114:9253–65
- Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 03, Revision B.04 ed. Wallingford, CT: Gaussian, Inc.; 2004
- Beck AD. Density-functional thermochemistry. 3. The role of exact exchanger. J Chem Phys 1983;98:5648–5652
- Lee CT, Yang WT, Parr RG. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 1988;37:785–9
- Wadt WR, Hay PJ. Ab initio effective core potentials for molecular calculations. Potentials for the transition metal atoms Sc to Hg. J Chem Phys 1985;82:284–98
- Ehlers AW, Bohme M, Dapprich S, et al. A set of f-polarization functions for pseudo-potential basis sets of the transition metals ScCu, Yg and LaAu. Chem Phys Lett 1993;208:111–14
- Hollwarth A, Bohme M, Dapprich S, et al. A set of d-polarization functions for pseudo-potential basis sets of the main group elements AlBi and f-type polarization functions for Zn, Cd, Hg. Chem Phys Lett 1993;208:237–40
- Reed AE, Curtiss LA, Weinhold F. Intermolecular interactions from a natural bond orbital, donor-acceptor viewpoint. Chem Rev 1988;88:899–926
- Cioslowski J. A new population analysis based on atomic polar tensors. J Am Chem Soc 1989;111:8333–6
- Ugliengo P, Viterbo D, Chiari G. MOLDRAW: molecular graphics on a personal computer. Z Kristallogr 1993;207:9–23